Canagliflozin vs Tremelimumab

## Canagliflozin vs Tremelimumab: Overview

This comparison examines the pharmacological differences between **Canagliflozin** and **Tremelimumab**.

## Mechanism of Action

**Canagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption and lowering blood glucose.

## Pharmacokinetics

**Half-life**: Canagliflozin — 10.6 hours; Tremelimumab — N/A.

## Chemical Properties

**Molecular Formula**: Canagliflozin — C24H25FO5S; Tremelimumab — N/A.

**Molecular Weight**: Canagliflozin — 444.5170 g/mol; Tremelimumab — N/A.

**Type**: Canagliflozin — Small molecule; Tremelimumab — Antibody.